NTRK2 and glioblastoma: These data suggest that the occurrence of the altered breakpoint exhibited by NACC2-NTRK2(ex4:ex15), resulting in greater stability of the fusion protein, may contribute to the more severe clinical outcome of pediatric glioblastoma [10].